Company / Working Capital per Share
NOVAVAX INC Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.23
FY2025
5-year range
-$9.98 / $3.23
FY2021-FY2025
Trend
+1869.4%
vs FY2024
Sector context
#136 of 210
Health Care
What the data says
Working Capital per Share changed +1869% YoY in FY2025, a notable deviation from the 9-year average annual change of +398%.
Based on SEC 10-K filings.
3.23 in FY2025 with a 5-year CAGR of -31.0%.
Improved from $-5.71 to $3.23 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -31.0%
- 10-Year CAGR
- -
Sector benchmark
#136 of 210 in Health CareTop 65% of 210This company $3.23 Sector average $118.60
▼
-97.3% below sector average
Key checks
Key Insights
- NOVAVAX INC's working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 1869.4% year-over-year.
- Ranks #136 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.23 | +1869.4% |
| FY2024 | -$0.18 | +96.8% |
| FY2023 | -$5.71 | +42.8% |
| FY2022 | -$9.98 | -200.9% |
| FY2021 | -$3.31 | -116.0% |
| FY2020 | $20.66 | +455.9% |
| FY2019 | $3.72 | +1529.4% |
| FY2018 | $0.23 | -52.3% |
| FY2017 | $0.48 | -41.7% |
| FY2016 | $0.82 | -7.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026